These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Dysphagia due to inclusion body myositis: case presentation and review of the literature. Ko EH; Rubin AD Ann Otol Rhinol Laryngol; 2014 Sep; 123(9):605-8. PubMed ID: 24634148 [TBL] [Abstract][Full Text] [Related]
43. Genetics in inclusion body myositis. Rothwell S; Lilleker JB; Lamb JA Curr Opin Rheumatol; 2017 Nov; 29(6):639-644. PubMed ID: 28777108 [TBL] [Abstract][Full Text] [Related]
44. Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis. Rygiel KA; Tuppen HA; Grady JP; Vincent A; Blakely EL; Reeve AK; Taylor RW; Picard M; Miller J; Turnbull DM Nucleic Acids Res; 2016 Jun; 44(11):5313-29. PubMed ID: 27131788 [TBL] [Abstract][Full Text] [Related]
45. Major histocompatibility complex class I and II expression in idiopathic inflammatory myopathy. Das L; Blumbergs PC; Manavis J; Limaye VS Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):539-42. PubMed ID: 23343957 [TBL] [Abstract][Full Text] [Related]
46. Pathophysiology of inflammatory and autoimmune myopathies. Dalakas MC Presse Med; 2011 Apr; 40(4 Pt 2):e237-47. PubMed ID: 21411269 [TBL] [Abstract][Full Text] [Related]
47. Interleukin-1 expression in inflammatory myopathies: evidence of marked immunoreactivity in sarcoid granulomas and muscle fibres showing ischaemic and regenerative changes. Authier FJ; Mhiri C; Chazaud B; Christov C; Cherin P; Barlovatz-Meimon G; Gherardi RK Neuropathol Appl Neurobiol; 1997 Apr; 23(2):132-40. PubMed ID: 9160898 [TBL] [Abstract][Full Text] [Related]
48. Inclusion-body myositis: clinical, diagnostic, and pathologic aspects. Engel WK; Askanas V Neurology; 2006 Jan; 66(2 Suppl 1):S20-9. PubMed ID: 16432141 [TBL] [Abstract][Full Text] [Related]
49. The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Rojana-udomsart A; Needham M; Luo YB; Fabian V; Walters S; Zilko PJ; Mastaglia FL Clin Neurol Neurosurg; 2011 Sep; 113(7):559-63. PubMed ID: 21507567 [TBL] [Abstract][Full Text] [Related]
52. Peripheral neuropathy of mitochondrial myopathies. Mizusawa H; Ohkoshi N; Watanabe M; Kanazawa I Rev Neurol (Paris); 1991; 147(6-7):501-7. PubMed ID: 1660182 [TBL] [Abstract][Full Text] [Related]
53. Myositis with endomysial cell invasion indicates inclusion body myositis even if other criteria are not fulfilled. van de Vlekkert J; Hoogendijk JE; de Visser M Neuromuscul Disord; 2015 Jun; 25(6):451-6. PubMed ID: 25817837 [TBL] [Abstract][Full Text] [Related]
54. Magnetic resonance imaging pattern recognition in sporadic inclusion-body myositis. Tasca G; Monforte M; De Fino C; Kley RA; Ricci E; Mirabella M Muscle Nerve; 2015 Dec; 52(6):956-62. PubMed ID: 25808807 [TBL] [Abstract][Full Text] [Related]
56. Mitochondrial DNA variants in inclusion body myositis. Kok CC; Boyt A; Gaudieri S; Martins R; Askanas V; Dalakas M; Kiers L; Mastaglia F; Garlepp M Neuromuscul Disord; 2000 Dec; 10(8):604-11. PubMed ID: 11053689 [TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E and apolipoprotein E messenger RNA in muscle of inclusion body myositis and myopathies. Mirabella M; Alvarez RB; Engel WK; Weisgraber KH; Askanas V Ann Neurol; 1996 Dec; 40(6):864-72. PubMed ID: 9007091 [TBL] [Abstract][Full Text] [Related]